Table: Sapporo Clinical Lab -2019/20 parent results

Sapporo Clinical Laboratory

13/05/2020 07:30

May 13 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           16.51           16.00          15.93         7.66    
               (+3.2 pct)      (-2.4 pct)     (-3.5 pct)    (-7.7 pct) 
  Operating      912 mln         758 mln                               
               (+20.3 pct)     (-21.3 pct)                             
  Recurring      944 mln         757 mln        589 mln      157 mln   
               (+24.6 pct)     (-24.1 pct)    (-37.6 pct)  (-68.0 pct) 
  Net            503 mln         486 mln        378 mln       97 mln   
               (+3.4 pct)      (-25.0 pct)    (-24.7 pct)  (-69.2 pct) 
  EPS          147.04 yen      141.84 yen     110.69 yen    28.52 yen  
  Ann Div       10.00 yen       10.00 yen      10.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       10.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T